Is The Public Engaged In Health Technology Assessment?

Published Jan 17, 2013
Queensland, Australia - Many health jurisdictions are moving towards greater public involvement in health technology assessment. Dr. Jennifer Whitty, PhD, Senior Lecturer with the Centre for Applied Health Economics and Deputy Director of the Population and Social Health Research Program at Griffith Health Institute, Griffith University explored how, why and to what extent patients and the public are engaged in health technology assessment processes and decision-making. For the exploration, Dr. Whitty undertook an international web-based survey of 39 organisations involved in health technology assessment. The survey findings suggest that two thirds of the responding organisations undertake public engagement activities such as public hearings, consultation via interactive websites, or focus groups. Mechanisms based on one-way communication or consultations were the most common; although, some organisations have used or intend to use participatory approaches such as citizens’ juries or consensus conferences. The findings suggest engagement is undertaken for a range of reasons, but a number of challenges to engagement were also identified. Dr. Whitty says “This survey provides further insight into the public engagement approaches that are used by health technology assessment organisations in practice.” The study, “An international survey of the public engagement practices of Health Technology Assessment Organisations,” is published inValue in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×